Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Classement en actions #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Prix de l'action
$5.84
Dernière synchronisation: 2025-04-02
Capitalisation boursière
$224.09M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Nevro Corp. (NVRO)

Catégorie

Healthcare
Ratio P/S pour Nevro Corp. (NVRO)
Ratio P/S au September 2026 TTM : 0.55
Selon les derniers rapports financiers et le cours de l'action de Nevro Corp., le ratio cours/ventes actuel (TTM) est 0.55. À la fin de 2023, le ratio P/S était de 1.82.
Historique du ratio P/S pour Nevro Corp. de 2012 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 0.55 61.32%
2024 0.34 -81.46%
2023 1.82 -47.08%
2022 3.44 -52.83%
2021 7.30 -54.68%
2020 16.10 73.55%
2019 9.28 207.44%
2018 3.02 -51.47%
2017 6.22 -31.35%
2016 9.06 -64.87%
2015 25.78 389.03%
2014 5.27 623.47%
2013 0.73 -22.76%
2012 0.94 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.10 647.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.80 775.92%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 407.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.42 523.39%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.02 1,362.88%
US